G20210A
· 14 retained evidence mentions
Source-grounded findings
Supporting evidence
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| variant | G20210A | “Evaluation of Factor V Leiden and prothrombin G20210A mutations in Sudanese women with severe preeclampsia.” | 0.82 | literature_variant_regex_v2 |
| variant | G20210A | “The association of the prothrombin G20210A single-nucleotide polymorphism and the risk of preeclampsia: Systematic review and meta-analysis.” | 0.82 | literature_variant_regex_v2 |
| variant | G20210A | “The enrolled patients (280) were evaluated for Triiodothyronine, Thyroxine, Thyroid stimulating hormone, prolactin, chromosomal analysis, Haemoglobin A1C, blood sugar, Magnetic resonance imaging, 3D-ultrasound, auto-antibodies profile (antiphospholipid antibodies, anticardiolipin antibodies, lupus anticoagulant, antinuclear antibodies, anti-thyroid antibodies and β2 glycoprotein1), torch profile (Toxoplasmo gondii, rubella, cytomegalo virus and herpes simplex virus), blood vitamin D3 levels, psychological factors, Body mass index and thrombotic factors (protein S and C deficiency, Prothrombin G20210A mutation, anti-thrombin III, Factor V Leiden and Methylenetetrahydrofolate reductase mutation), uterosalpingography (hysteronsalpingography) and hysteroscopy.” | 0.82 | literature_variant_regex_v2 |
| variant | G20210A | “The Doppler study showed a thrombus in the saphenous vein, and complementary genetic screening investigations revealed heterozygous mutation for prothrombin (G20210A).” | 0.82 | literature_variant_regex_v2 |
| variant | G20210A | “Citrated blood samples of patients and controls were used for coagulation assays, and DNAs isolated from EDTA-blood samples were used for the detection of Factor V Leiden and prothrombin G20210A mutations using multiplex polymerase chain reaction-restriction fragment length polymorphism analysis.” | 0.82 | literature_variant_regex_v2 |
| variant | G20210A | “Analysis of factor V Leiden (G1691A) and factor II (G20210A) mutations was also done.” | 0.82 | literature_variant_regex_v2 |
| variant | G20210A | “Molecular characterization of factor V leiden G1691A and prothrombin G20210A mutations in Saudi newborns with stroke.” | 0.82 | literature_variant_regex_v2 |
| variant | G20210A | “Factor V Leiden and prothrombin G20210A gene mutations in women with a history of thrombosis during pregnancy.” | 0.82 | literature_variant_regex_v2 |
| variant | G20210A | “OBJECTIVE: To study the frequency of Factor V Leiden (FVL), prothrombin gene mutation G20210A and methylenetetrahydrofolate reductase C677T in patients with acute pulmonary embolism (PE); and to investigate whether these factors are more frequent in patients who have no obvious risk factors for venous thrombo-embolism compared to those with obvious risk factors.” | 0.82 | literature_variant_regex_v2 |
| variant | G20210A | “Moreover, thrombophilic states such as prothrombin G20210A mutation and factor V Leiden are now known to cause arterial stroke as well as venous thrombosis.” | 0.82 | literature_variant_regex_v2 |
| variant | G20210A | “Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs.” | 0.82 | literature_variant_regex_v2 |
| variant | G20210A | “Prevalence of factor V Leiden and prothrombin G20210A gene mutation.” | 0.82 | literature_variant_regex_v2 |
| variant | G20210A | “Prevalence of factor V Leiden and prothrombin G20210A gene mutation.” | 0.82 | literature_variant_regex_v2 |
| variant | G20210A | “The clinical applications of molecular techniques have allowed identification of important inherited, yet not uncommon, risk factors for VTE, such as mutations that cause Factor V Leiden and prothrombin G20210A.” | 0.82 | literature_variant_regex_v2 |